The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
TB Vaccines-Global Market Insights and Sales Trends 2025
Synopsis
Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch. Today, the only effective tuberculosis vaccine in common use is bacilli Calmette-Guérin (BCG), first used in 1921.About three out of every 10,000 people who get the vaccine experience side effects, which are usually minor except in severely immuno-depressed individuals. While BCG immunization provides fairly effective protection for infants and young children, (including defence against TB meningitis and miliary TB), its efficacy in adults is variable, ranging from 0% to 80%.Several variables have been considered as responsible for the varying outcomes. Demand for TB immunotherapy advancement exists because the disease has become increasingly drug-resistant.
The global TB Vaccines market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of TB Vaccines in various end use industries. The expanding demands from the Hospitals, Private Clinics and Research Institutes,, are propelling TB Vaccines market. Immunotherapeutic Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Booster Vaccines segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for TB Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global TB Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global TB Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, TB Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of TB Vaccines covered in this report include Merck & Co.,Inc, Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute, India Pvt. Ltd, InterVax Ltd, GreenSignal and Bio Pharma Limited, etc.
The global TB Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck & Co.,Inc
Sanofi Pasteur
Japan BCG Laboratory
China National Biotec Group
Serum Institute
India Pvt. Ltd
InterVax Ltd
GreenSignal
Bio Pharma Limited
Statens Serum Institut
Global TB Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global TB Vaccines market, Segment by Type:
Immunotherapeutic Vaccines
Booster Vaccines
Others
Global TB Vaccines market, by Application
Hospitals
Private Clinics
Research Institutes
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of TB Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of TB Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch. Today, the only effective tuberculosis vaccine in common use is bacilli Calmette-Guérin (BCG), first used in 1921.About three out of every 10,000 people who get the vaccine experience side effects, which are usually minor except in severely immuno-depressed individuals. While BCG immunization provides fairly effective protection for infants and young children, (including defence against TB meningitis and miliary TB), its efficacy in adults is variable, ranging from 0% to 80%.Several variables have been considered as responsible for the varying outcomes. Demand for TB immunotherapy advancement exists because the disease has become increasingly drug-resistant.
The global TB Vaccines market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of TB Vaccines in various end use industries. The expanding demands from the Hospitals, Private Clinics and Research Institutes,, are propelling TB Vaccines market. Immunotherapeutic Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Booster Vaccines segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for TB Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global TB Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global TB Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, TB Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of TB Vaccines covered in this report include Merck & Co.,Inc, Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute, India Pvt. Ltd, InterVax Ltd, GreenSignal and Bio Pharma Limited, etc.
The global TB Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck & Co.,Inc
Sanofi Pasteur
Japan BCG Laboratory
China National Biotec Group
Serum Institute
India Pvt. Ltd
InterVax Ltd
GreenSignal
Bio Pharma Limited
Statens Serum Institut
Global TB Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global TB Vaccines market, Segment by Type:
Immunotherapeutic Vaccines
Booster Vaccines
Others
Global TB Vaccines market, by Application
Hospitals
Private Clinics
Research Institutes
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of TB Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of TB Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 TB Vaccines Market Overview
1.1 TB Vaccines Product Overview
1.2 TB Vaccines Market Segment by Type
1.2.1 Immunotherapeutic Vaccines
1.2.2 Booster Vaccines
1.2.3 Others
1.3 Global TB Vaccines Market Size by Type
1.3.1 Global TB Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global TB Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global TB Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America TB Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe TB Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific TB Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America TB Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa TB Vaccines Sales Breakdown by Type (2018-2023)
2 Global TB Vaccines Market Competition by Company
2.1 Global Top Players by TB Vaccines Sales (2018-2023)
2.2 Global Top Players by TB Vaccines Revenue (2018-2023)
2.3 Global Top Players by TB Vaccines Price (2018-2023)
2.4 Global Top Manufacturers TB Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 TB Vaccines Market Competitive Situation and Trends
2.5.1 TB Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by TB Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in TB Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into TB Vaccines Market
2.8 Key Manufacturers TB Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 TB Vaccines Status and Outlook by Region
3.1 Global TB Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global TB Vaccines Historic Market Size by Region
3.2.1 Global TB Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global TB Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global TB Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global TB Vaccines Forecasted Market Size by Region
3.3.1 Global TB Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global TB Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global TB Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global TB Vaccines by Application
4.1 TB Vaccines Market Segment by Application
4.1.1 Hospitals
4.1.2 Private Clinics
4.1.3 Research Institutes
4.2 Global TB Vaccines Market Size by Application
4.2.1 Global TB Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global TB Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global TB Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America TB Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe TB Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific TB Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America TB Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa TB Vaccines Sales Breakdown by Application (2018-2023)
5 North America TB Vaccines by Country
5.1 North America TB Vaccines Historic Market Size by Country
5.1.1 North America TB Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America TB Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America TB Vaccines Sales in Value by Country (2018-2023)
5.2 North America TB Vaccines Forecasted Market Size by Country
5.2.1 North America TB Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America TB Vaccines Sales in Value by Country (2024-2029)
6 Europe TB Vaccines by Country
6.1 Europe TB Vaccines Historic Market Size by Country
6.1.1 Europe TB Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe TB Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe TB Vaccines Sales in Value by Country (2018-2023)
6.2 Europe TB Vaccines Forecasted Market Size by Country
6.2.1 Europe TB Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe TB Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific TB Vaccines by Region
7.1 Asia-Pacific TB Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific TB Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific TB Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific TB Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific TB Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific TB Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific TB Vaccines Sales in Value by Region (2024-2029)
8 Latin America TB Vaccines by Country
8.1 Latin America TB Vaccines Historic Market Size by Country
8.1.1 Latin America TB Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America TB Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America TB Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America TB Vaccines Forecasted Market Size by Country
8.2.1 Latin America TB Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America TB Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa TB Vaccines by Country
9.1 Middle East and Africa TB Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa TB Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa TB Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa TB Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa TB Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa TB Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa TB Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck & Co.,Inc
10.1.1 Merck & Co.,Inc Company Information
10.1.2 Merck & Co.,Inc Introduction and Business Overview
10.1.3 Merck & Co.,Inc TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck & Co.,Inc TB Vaccines Products Offered
10.1.5 Merck & Co.,Inc Recent Development
10.2 Sanofi Pasteur
10.2.1 Sanofi Pasteur Company Information
10.2.2 Sanofi Pasteur Introduction and Business Overview
10.2.3 Sanofi Pasteur TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Pasteur TB Vaccines Products Offered
10.2.5 Sanofi Pasteur Recent Development
10.3 Japan BCG Laboratory
10.3.1 Japan BCG Laboratory Company Information
10.3.2 Japan BCG Laboratory Introduction and Business Overview
10.3.3 Japan BCG Laboratory TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Japan BCG Laboratory TB Vaccines Products Offered
10.3.5 Japan BCG Laboratory Recent Development
10.4 China National Biotec Group
10.4.1 China National Biotec Group Company Information
10.4.2 China National Biotec Group Introduction and Business Overview
10.4.3 China National Biotec Group TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 China National Biotec Group TB Vaccines Products Offered
10.4.5 China National Biotec Group Recent Development
10.5 Serum Institute
10.5.1 Serum Institute Company Information
10.5.2 Serum Institute Introduction and Business Overview
10.5.3 Serum Institute TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Serum Institute TB Vaccines Products Offered
10.5.5 Serum Institute Recent Development
10.6 India Pvt. Ltd
10.6.1 India Pvt. Ltd Company Information
10.6.2 India Pvt. Ltd Introduction and Business Overview
10.6.3 India Pvt. Ltd TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 India Pvt. Ltd TB Vaccines Products Offered
10.6.5 India Pvt. Ltd Recent Development
10.7 InterVax Ltd
10.7.1 InterVax Ltd Company Information
10.7.2 InterVax Ltd Introduction and Business Overview
10.7.3 InterVax Ltd TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 InterVax Ltd TB Vaccines Products Offered
10.7.5 InterVax Ltd Recent Development
10.8 GreenSignal
10.8.1 GreenSignal Company Information
10.8.2 GreenSignal Introduction and Business Overview
10.8.3 GreenSignal TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 GreenSignal TB Vaccines Products Offered
10.8.5 GreenSignal Recent Development
10.9 Bio Pharma Limited
10.9.1 Bio Pharma Limited Company Information
10.9.2 Bio Pharma Limited Introduction and Business Overview
10.9.3 Bio Pharma Limited TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Bio Pharma Limited TB Vaccines Products Offered
10.9.5 Bio Pharma Limited Recent Development
10.10 Statens Serum Institut
10.10.1 Statens Serum Institut Company Information
10.10.2 Statens Serum Institut Introduction and Business Overview
10.10.3 Statens Serum Institut TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Statens Serum Institut TB Vaccines Products Offered
10.10.5 Statens Serum Institut Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 TB Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 TB Vaccines Industrial Chain Analysis
11.4 TB Vaccines Market Dynamics
11.4.1 TB Vaccines Industry Trends
11.4.2 TB Vaccines Market Drivers
11.4.3 TB Vaccines Market Challenges
11.4.4 TB Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 TB Vaccines Distributors
12.3 TB Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
